Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1992 Mar;60(3):1041–1046. doi: 10.1128/iai.60.3.1041-1046.1992

Effect of lectins on hepatic clearance and killing of Candida albicans by the isolated perfused mouse liver.

R T Sawyer 1, R E Garner 1, J A Hudson 1
PMCID: PMC257591  PMID: 1541519

Abstract

The isolated perfused mouse liver model was used to study the effects of various lectins on hepatic trapping and killing of Candida albicans. After mouse livers were washed with 20 to 30 ml of perfusion buffer, 10(6) C. albicans CFU were infused into the livers. At the time of recovery, 63% +/- 2% (mean +/- standard error of the mean) of the infused C. albicans CFU were recovered from the liver and 14% +/- 1% were recovered from the effluent for a total recovery of 77% +/- 2%. This indicated that 86% +/- 9% of the original inoculum was trapped by the liver and that 23% +/- 2% was killed within the liver. When included in both preperfusion and postperfusion buffers (0.2 mg of lectin per ml), Ulex europeaus lectin (binding specificity for fucose) decreased hepatic trapping of C. albicans by 37% and eluted trapped C. albicans from the liver only when included in postperfusion buffer. By comparison, treatment of C. albicans with U. europeaus lectin before infusion had no effect on the trapping or killing of yeast cells. When Lens culinaris lectin (binding specificity for mannose) was included in the perfusion buffers, hepatic killing of C. albicans increased by 16% with no significant effect on hepatic killing when yeast cells were treated with L. culinaris lectin before infusion. Forty to 55% of the infused C. albicans were killed when concanavalin A (binding specificities for mannose and glucose), Glycine max (binding specificity for N-acetylgalactosamine), or Arachis hypogea (binding specificity for galactose) lectin was included in the perfusion buffer or when yeast cells were treated with these lectins before their infusion. When C. albicans was treated with concanavalin A at a concentration of less than 0.02 mg/ml, hepatic killing of yeast cells was not significantly increased. The data suggest that a fucose-containing receptor on the surface of either sinusoidal endothelial cells or Kupffer cells is involved in the trapping of C. albicans by the perfused mouse liver. Moreover, lectins with binding specificities for mannose, N-acetylgalactosamine, and galactose increased hepatic killing of C. albicans.

Full text

PDF
1041

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonventre P. F., Oxman E. Phagocytosis and intracellular disposition of viable bacteria by the isolated perfused rat liver. J Reticuloendothel Soc. 1965 Nov;2(4):313–325. [PubMed] [Google Scholar]
  2. Brummer E., Stevens D. A. Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines. Clin Exp Immunol. 1987 Dec;70(3):520–528. [PMC free article] [PubMed] [Google Scholar]
  3. Calderone R. A., Braun P. C. Adherence and receptor relationships of Candida albicans. Microbiol Rev. 1991 Mar;55(1):1–20. doi: 10.1128/mr.55.1.1-20.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ding A., Nathan C. Analysis of the nonfunctional respiratory burst in murine Kupffer cells. J Exp Med. 1988 Mar 1;167(3):1154–1170. doi: 10.1084/jem.167.3.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lehrer R. I., Cline M. J. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest. 1969 Aug;48(8):1478–1488. doi: 10.1172/JCI106114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lehrer R. I., Ladra K. M., Hake R. B. Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbit, and guinea pig leukocytes. Infect Immun. 1975 Jun;11(6):1226–1234. doi: 10.1128/iai.11.6.1226-1234.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lehrer R. I. The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms. J Clin Invest. 1975 Feb;55(2):338–346. doi: 10.1172/JCI107937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Moon R. J., Vrable R. A., Broka J. A. In situ separation of bacterial trapping and killing functions of the perfused liver. Infect Immun. 1975 Aug;12(2):411–418. doi: 10.1128/iai.12.2.411-418.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Patterson-Delafield J., Martinez R. J., Lehrer R. I. Microbicidal cationic proteins in rabbit alveolar macrophages: a potential host defense mechanism. Infect Immun. 1980 Oct;30(1):180–192. doi: 10.1128/iai.30.1.180-192.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sawyer R. T. Experimental pulmonary candidiasis. Mycopathologia. 1990 Feb;109(2):99–109. doi: 10.1007/BF00436790. [DOI] [PubMed] [Google Scholar]
  11. Sawyer R. T., Harmsen A. G. The relative contribution of resident pulmonary alveolar macrophage and inflammatory polymorphonuclear neutrophils in host resistance to pulmonary infection by Candida albicans. Mycopathologia. 1989 Nov;108(2):95–105. doi: 10.1007/BF00436059. [DOI] [PubMed] [Google Scholar]
  12. Sawyer R. T., Horst M. N., Garner R. E., Hudson J., Jenkins P. R., Richardson A. L. Altered hepatic clearance and killing of Candida albicans in the isolated perfused mouse liver model. Infect Immun. 1990 Sep;58(9):2869–2874. doi: 10.1128/iai.58.9.2869-2874.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sawyer R. T., Moon R. J., Beneke E. S. Hepatic clearance of Candida albicans in rats. Infect Immun. 1976 Dec;14(6):1348–1355. doi: 10.1128/iai.14.6.1348-1355.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sawyer R. T., Moon R. J., Beneke E. S. Trapping and killing of Candida albicans by Corynebacterium parvum-activated livers. Infect Immun. 1981 May;32(2):945–950. doi: 10.1128/iai.32.2.945-950.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sawyer R. T. The effect of monosaccharides on in situ hepatic trapping of Candida albicans. Mycopathologia. 1988 Nov;104(2):81–85. doi: 10.1007/BF00436931. [DOI] [PubMed] [Google Scholar]
  16. Schwocho L. R., Moon R. J. Clearance and killing of Candida albicans in the perfused mouse liver. Mycopathologia. 1981 Dec 11;76(3):175–183. doi: 10.1007/BF00437198. [DOI] [PubMed] [Google Scholar]
  17. Sorokin S. P., Hoyt R. F., Jr, McNelly N. A. Nonimmune-mediated phagocytosis by "premedullary" lung macrophages: effects of concanavalin A, tuftsin, and macrophage-inhibitory peptide. Anat Rec. 1989 Jan;223(1):55–61. doi: 10.1002/ar.1092230109. [DOI] [PubMed] [Google Scholar]
  18. Watanabe K., Kagaya K., Yamada T., Fukazawa Y. Mechanism for candidacidal activity in macrophages activated by recombinant gamma interferon. Infect Immun. 1991 Feb;59(2):521–528. doi: 10.1128/iai.59.2.521-528.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wilson M. E., Hardin K. K. The major concanavalin A-binding surface glycoprotein of Leishmania donovani chagasi promastigotes is involved in attachment to human macrophages. J Immunol. 1988 Jul 1;141(1):265–272. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES